News

DEADLINE ALERT for VRCA, DB and BAYRY: Frank R. Cruz legislation companies are reminding buyers of sophistication motion lawsuits on behalf of shareholders – Yahoo Finance

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "LOS ANGELES, August 19, 2020 (GLOBE NEWSWIRE) – Frank R. Cruz's law firms reminds investors that class action lawsuits have been filed on behalf of the shareholders of the following publicly traded companies. Investors have until the deadlines set out below to file a motion from the lead plaintiff.
"data-reactid =" 12 "> LOS ANGELES, August 19, 2020 (GLOBE NEWSWIRE) – Frank R. Cruz's law firm reminds investors that class action lawsuits have been filed on behalf of the shareholders of the following listed companies Time to file lead plaintiff's motion within the deadlines listed below.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Investors who suffer losses in their investments are asked to Contacting Frank R. Cruz's law firms to discuss their legal rights in these class action lawsuits at 310-914-5007 or email at fcruz@frankcruzlaw.com. "data-reactid =" 13 "> Investors who suffer losses in their investments are asked to contact the law firm of Frank R. Cruz at 310-914-5007 or by email at fcruz @ frankcruzlaw, to discuss their legal rights in these class actions .com.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Verrica Pharmaceuticals Inc. (NASDAQ: VRCA)
Teaching time: September 16, 2019 – June 29, 2020
Deadline of the main plaintiff: September 14, 2020"data-reactid =" 14 ">Verrica Pharmaceuticals Inc. (NASDAQ: VRCA)
Teaching time: September 16, 2019 – June 29, 2020
Deadline of the main plaintiff: September 14, 2020

The complaint filed in this class action alleges that throughout the class period, defendants made materially false and / or misleading statements and did not disclose material adverse facts about the company's business, business, and prospects. In particular, Defendants have failed to advise investors: (1) that the Company's proprietary applicator used for VP-102 poses certain security risks if instructions are not properly followed; (2) that as a result, Verrica would incorporate certain user functions in order to reduce the security risk; (3) that adding the user role would require additional testing of stability-supporting data; (4) that regulatory approval for VP-102 would be reasonably delayed due to the foregoing; and (5) that Defendants' positive statements about the business, operations and prospects of the Company as a result of the foregoing were materially misleading and / or were unfounded.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Deutsche Bank Aktiengesellschaft (NYSE: DB)
Classes: November 7, 2017 – July 6, 2020
Deadline of the main plaintiff: September 14, 2020"data-reactid =" 20 ">Deutsche Bank Aktiengesellschaft (NYSE: DB)
Classes: November 7, 2017 – July 6, 2020
Deadline of the main plaintiff: September 14, 2020

The complaint filed in this class action alleges that throughout the class period, defendants made materially false and / or misleading statements and did not disclose material adverse facts about the company's business, business, and prospects. Specifically, Defendants have failed to provide investors with information: (1) Deutsche Bank has failed to address deficiencies related to anti-money laundering, disclosure controls and procedures, internal controls over financial reporting and the difficult state of its US operations . (2) As a result, the Bank has not properly monitored clients identified by the Bank itself as high risk, including but not limited to convicted sex offender Jeffrey Epstein ("Epstein") and two correspondent banks, Danske Estonia and FBME Bank, both of which are subject previous financial misconduct scandals; (3) that the foregoing, once disclosed, is expected to have a materially negative impact on the Bank's financial results and reputation; and (4) as a result, the Bank's public statements have been materially false and misleading at all relevant times.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Bayer Aktiengesellschaft (OTC: BAYRY)
Classes: May 23, 2016 – March 19, 2019
Deadline of the main plaintiff: September 14, 2020"data-reactid =" 22 ">Bayer Aktiengesellschaft (OTC: BAYRY)
Classes: May 23, 2016 – March 19, 2019
Deadline of the main plaintiff: September 14, 2020

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Shareholders with a loss of $ 500,000 or more are encouraged to contact the company"data-reactid =" 23 ">Shareholders with a loss of $ 500,000 or more are encouraged to contact the company

The complaint alleges that throughout the teaching period, defendants made false and / or misleading statements and / or failed to disclose: (1) that the acquisition of Monsanto would result in the company being subject to massive judgments and reputational damage if Litigation related to Monsanto's Roundup product was successful; (2) that the Company's positive statements about the prospect of the Monsanto acquisition and the benefits it would bring were false; (3) As a result, the Society's public statements were false and materially misleading throughout the teaching period.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Follow us for updates on Twitter: twitter.com/FRC_LAW. "data-reactid =" 25 "> Follow us for updates on Twitter: twitter.com/FRC_LAW.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "To be a member of these class actions you must You must take no action at this point. You may retain an attorney of your choice or take no action and remain an absent member of the class action. If you would like to learn more about, or have questions about, this announcement, or your rights or interests in relation to these matters, please contact Frank R. Cruz of the Frank R. Cruz Law Firms, Avenue of the Stars 1999, Suite 1100, Los Angeles, California 90067, at 310-914-5007, by email at info@frankcruzlaw.comor visit our website at www.frankcruzlaw.com. When inquiring by email, please include your mailing address, telephone number and number of shares purchased. "Data-reactid =" 26 "> You do not have to take any action at this time to become a member of these class actions Keep the advice of your choice or take no action and remain an absent member of the class action. If you want to learn more about these class actions or have any questions about this announcement or your rights or interests in relation to these matters, please contact Frank R. Cruz of the Frank R. Cruz Law Offices, Avenue of the Stars 1999, Suite 1100, Los Angeles, California 90067, at 310 -914-5007, by email to info@frankcruzlaw.com or visit our website at www.frankcruzlaw.com If you inquire by email, please include your mailing address, telephone number and the number of shares purchased.

This press release may be viewed as a solicitor advertisement in some jurisdictions under applicable laws and ethical rules.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "contacts"data-reactid =" 28 ">contacts

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "The law firms of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com"data-reactid =" 29 "> The law offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

0 Comments
Share

labsurlab

Reply your comment

Your email address will not be published. Required fields are marked*